Pop Test Oncology LLC
Palisades Therapeutics is dedicated to creating, developing, and protecting innovative products and technologies aimed at significantly improving patients' lives. The company focuses on Diagnostics, Therapeutics, and Devices, with a mission to advance modern medical practice through innovative solutions. They operate by out-licensing or selling their products and intellectual property for global commercialization, supported by a team of leading scientists, physicians, and professionals. Palisades collaborates with numerous prestigious institutions and maintains a strong portfolio of programs across various medical and agricultural fields.
Industries
Pop Test Oncology LLC
Products
Saliva-based colorimetric point-of-care diagnostic
A non-invasive saliva-based test format that uses colorimetric test pads and a smartphone app to quantify biomarkers such as glucose, uric acid and cholesterol.
Battery-operated modular lateral flow diagnostic device
A self-contained lateral flow platform with integrated electronics (audio/visual outputs, heat-generating circuitry, modular memory and logic) for immunoassay testing.
Ingestible sampling and targeted delivery devices
Ingestible devices designed to sample gut microbiota for metagenomic analysis, enable targeted drug delivery to intestinal regions, and provide digital accountability for individual doses.
3D liver culture and extracorporeal liver assist systems
Research-stage 3D hepatic culture systems for compound screening and extracorporeal liver assist devices intended to support hepatic function in acute or chronic failure.
Drug development pipeline (small molecules and adjunctive agents)
Pipeline of preclinical and clinical-stage small-molecule therapeutics and adjunctive agents targeting antiviral, oncology, neuroinflammation and antibiotic potentiation applications.
Saliva-based colorimetric point-of-care diagnostic
A non-invasive saliva-based test format that uses colorimetric test pads and a smartphone app to quantify biomarkers such as glucose, uric acid and cholesterol.
Battery-operated modular lateral flow diagnostic device
A self-contained lateral flow platform with integrated electronics (audio/visual outputs, heat-generating circuitry, modular memory and logic) for immunoassay testing.
Ingestible sampling and targeted delivery devices
Ingestible devices designed to sample gut microbiota for metagenomic analysis, enable targeted drug delivery to intestinal regions, and provide digital accountability for individual doses.
3D liver culture and extracorporeal liver assist systems
Research-stage 3D hepatic culture systems for compound screening and extracorporeal liver assist devices intended to support hepatic function in acute or chronic failure.
Drug development pipeline (small molecules and adjunctive agents)
Pipeline of preclinical and clinical-stage small-molecule therapeutics and adjunctive agents targeting antiviral, oncology, neuroinflammation and antibiotic potentiation applications.
Services
Out-licensing and commercialization of IP
Licensing or sale of developed products and associated intellectual property to third parties for global commercialization.
Collaborative research and development partnerships
Partnerships with academic, governmental and industry collaborators to advance diagnostics, therapeutics and devices through joint research and data generation.
Intellectual property and patent prosecution support
Coordination with regional IP counsel for global patent filing and prosecution to protect technologies prior to commercialization.
Out-licensing and commercialization of IP
Licensing or sale of developed products and associated intellectual property to third parties for global commercialization.
Collaborative research and development partnerships
Partnerships with academic, governmental and industry collaborators to advance diagnostics, therapeutics and devices through joint research and data generation.
Intellectual property and patent prosecution support
Coordination with regional IP counsel for global patent filing and prosecution to protect technologies prior to commercialization.
Expertise Areas
- Saliva diagnostics and point-of-care biomarker measurement
- Lateral flow and point-of-care diagnostic device development
- Ingestible device development and targeted intestinal delivery
- Preclinical drug discovery and development (antivirals, oncology, antibiotics adjuncts)
Key Technologies
- Lateral flow immunoassay
- Colorimetric smartphone image analysis
- Ingestible sampling devices
- Metagenomic sequencing workflows